Docket #: S15-017
Gene sequences for the biosynthesis of podophyllotoxin derivatives
Stanford researchers at the Sattely Lab have discovered six podophyllotoxin biosynthetic genes and their polypeptide products from the plant, Podophyllum hexandrum (mayapple). This discovery enables the engineering of alternative biological hosts for the production of a direct precursor for the semi-synthesis of Etopophos, an FDA approved anticancer agent. The genes and their polypeptide products were elucidated by RNA-Seq analysis and their activities were demonstrated by in vivo and in vitro testing.
Figure
Stage of Research
Applications
- Biosynthesis of a podophyllotoxin derivative as a precursor to the FDA approved anticancer agent, Etopophos, in engineered biological hosts
Advantages
- Enables a preferred, biosynthetic method for producing podophyllotoxin by engineering a microbial host for industrial fermentation
- Less costly and more direct production route to Etopophos
- Relieves severe pressure on endangered natural sources. Podophyllum hexandrum, a slow-growing plant, is regarded as an endangered species
Publications
- Lau, W. and Sattely, E. S. “Six genes that complete biosynthetic pathway to the etoposide aglycone in Mayapple” Science, 2015, 349, 1224-1228.
Related Links
Patents
- Published Application: 20170088872
Similar Technologies
-
System and methods for optogenetic stimulation and inhibition of pain S13-278System and methods for optogenetic stimulation and inhibition of pain
-
Non-immunogenic Destabilizing Domains S17-025Non-immunogenic Destabilizing Domains
-
Mitochondrial Aldehyde Dehyrogenase-2 Modulators and Methods of Use Thereof S11-154Mitochondrial Aldehyde Dehyrogenase-2 Modulators and Methods of Use Thereof